ClinicalTrials.Veeva

Menu

Wide-field Optical Coherence Tomography Imaging of Excised Breast Tissue.

P

Perimeter Medical Imaging

Status

Completed

Conditions

Breast Cancer Female

Treatments

Device: Investigational WF-OCT device

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04242277
PER-19-03

Details and patient eligibility

About

This is a single-arm, multi-center data collection study designed to collect WF-OCT imaging data of excised breast tissue margins with corresponding margin status from histopathology.

Full description

Data collected during this study will be used for product development by the study sponsor, Perimeter Medical Imaging.

Enrollment

198 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female
  • Age 18 years or older
  • Invasive ductal breast carcinoma and ductal carcinoma in situ having undergone breast conservation surgery
  • May include neo-adjuvant treated subjects (chemotherapeutic, endocrine therapy, or radiation)
  • Ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

  • Metastatic cancer (Stage IV)
  • Lobular carcinoma as primary diagnosis

Trial design

198 participants in 1 patient group

WF-OCT imaging of excised breast lumpectomy tissue
Description:
Excised lumpectomy tissue from all consented patients will be imaged on an investigational OCT-based device. No clinical decisions will be made based on the images acquired.
Treatment:
Device: Investigational WF-OCT device

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems